Ipca Laboratories's stock experienced a decline of 2.08% during today's trading session, with the price reaching Rs 1,386.30. This movement reflects a notable shift in investor sentiment.
The decline places Ipca Laboratories among the losers in the NIFTY MIDCAP 150 index. The stock's performance is closely watched by investors, especially given its presence in this key mid-cap index.
Quarterly Performance:
| Period | Revenue (Cr) | Net Profit (Cr) | EPS |
|---|---|---|---|
| Mar 2025 | 2,246.69 | 65.78 | 2.67 |
| Dec 2024 | 2,245.37 | 277.33 | 9.78 |
| Sep 2024 | 2,354.90 | 245.44 | 9.05 |
| Jun 2024 | 2,092.63 | 198.98 | 7.58 |
| Mar 2024 | 2,033.01 | 2.91 | 2.35 |
| Year | Revenue (Cr) | Net Profit (Cr) | EPS | BVPS | ROE (%) | Debt to Equity |
|---|---|---|---|---|---|---|
| 2024 | 7,705.04 | 529.21 | 25.82 | 304.57 | 8.64 | 0.22 |
| 2023 | 6,244.32 | 491.93 | 18.58 | 233.16 | 8.06 | 0.25 |
| 2022 | 5,829.79 | 910.95 | 34.85 | 219.51 | 16.09 | 0.14 |
| 2021 | 5,419.99 | 1,148.84 | 45.01 | 371.79 | 24.24 | 0.05 |
| 2020 | 4,648.71 | 611.37 | 47.77 | 288.18 | 16.71 | 0.11 |
The latest quarterly results show a revenue of Rs 2,246.69 Cr for March 2025, with a net profit of Rs 65.78 Cr and EPS of Rs 2.67. Monitoring these trends is essential for understanding the stock's potential trajectory.
The company’s performance ratios provide further insights. The debt-to-equity ratio has remained relatively stable, and various margin ratios reflect the company's profitability and efficiency. Ipca Laboratories’ financial health and market position will likely continue to influence its stock performance.
With the stock's current price at Rs 1,386.30, Ipca Laboratories's performance is keenly observed by investors in the pharmaceutical sector.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.